BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 17982482)

  • 1. In vitro and in vivo pharmacological profile of UFP-512, a novel selective delta-opioid receptor agonist; correlations between desensitization and tolerance.
    Aguila B; Coulbault L; Boulouard M; Léveillé F; Davis A; Tóth G; Borsodi A; Balboni G; Salvadori S; Jauzac P; Allouche S
    Br J Pharmacol; 2007 Dec; 152(8):1312-24. PubMed ID: 17982482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anxiolytic- and antidepressant-like activities of H-Dmt-Tic-NH-CH(CH2-COOH)-Bid (UFP-512), a novel selective delta opioid receptor agonist.
    Vergura R; Balboni G; Spagnolo B; Gavioli E; Lambert DG; McDonald J; Trapella C; Lazarus LH; Regoli D; Guerrini R; Salvadori S; Caló G
    Peptides; 2008 Jan; 29(1):93-103. PubMed ID: 18069089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dmt-Tic-NH-CH2-Bid (UFP-502), a potent DOP receptor agonist: in vitro and in vivo studies.
    Vergura R; Valenti E; Hebbes CP; Gavioli EC; Spagnolo B; McDonald J; Lambert DG; Balboni G; Salvadori S; Regoli D; Calo' G
    Peptides; 2006 Dec; 27(12):3322-30. PubMed ID: 16963157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different kinases desensitize the human delta-opioid receptor (hDOP-R) in the neuroblastoma cell line SK-N-BE upon peptidic and alkaloid agonists.
    Marie N; Aguila B; Hasbi A; Davis A; Jauzac P; Allouche S
    Cell Signal; 2008 Jun; 20(6):1209-20. PubMed ID: 18395423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological characterization of the bifunctional opioid ligand H-Dmt-Tic-Gly-NH-Bzl (UFP-505).
    Dietis N; McDonald J; Molinari S; Calo G; Guerrini R; Rowbotham DJ; Lambert DG
    Br J Anaesth; 2012 Feb; 108(2):262-70. PubMed ID: 22194444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The novel delta opioid receptor agonist UFP-512 dually modulates motor activity in hemiparkinsonian rats via control of the nigro-thalamic pathway.
    Mabrouk OS; Marti M; Salvadori S; Morari M
    Neuroscience; 2009 Dec; 164(2):360-9. PubMed ID: 19729051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo properties of KNT-127, a novel δ opioid receptor agonist: receptor internalization, antihyperalgesia and antidepressant effects in mice.
    Nozaki C; Nagase H; Nemoto T; Matifas A; Kieffer BL; Gaveriaux-Ruff C
    Br J Pharmacol; 2014 Dec; 171(23):5376-86. PubMed ID: 25048778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidepressant-like and anxiolytic-like effects following activation of the μ-δ opioid receptor heteromer in the nucleus accumbens.
    Kabli N; Nguyen T; Balboni G; O'Dowd BF; George SR
    Mol Psychiatry; 2014 Sep; 19(9):986-94. PubMed ID: 24061495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agonist-induced phosphorylation bar code and differential post-activation signaling of the delta opioid receptor revealed by phosphosite-specific antibodies.
    Mann A; Liebetrau S; Klima M; Dasgupta P; Massotte D; Schulz S
    Sci Rep; 2020 May; 10(1):8585. PubMed ID: 32444688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptidic delta opioid receptor agonists produce antidepressant-like effects in the forced swim test and regulate BDNF mRNA expression in rats.
    Torregrossa MM; Jutkiewicz EM; Mosberg HI; Balboni G; Watson SJ; Woods JH
    Brain Res; 2006 Jan; 1069(1):172-81. PubMed ID: 16364263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remifentanil produces cross-desensitization and tolerance with morphine on the mu-opioid receptor.
    Nowoczyn M; Marie N; Coulbault L; Hervault M; Davis A; Hanouz JL; Allouche S
    Neuropharmacology; 2013 Oct; 73():368-79. PubMed ID: 23792280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic antidepressant-like effects between a kappa opioid antagonist (LY2444296) and a delta opioid agonist (ADL5859) in the mouse forced swim test.
    Huang P; Tunis J; Parry C; Tallarida R; Liu-Chen LY
    Eur J Pharmacol; 2016 Jun; 781():53-9. PubMed ID: 27044434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment With the Delta Opioid Agonist UFP-512 Alleviates Chronic Inflammatory and Neuropathic Pain: Mechanisms Implicated.
    Polo S; Díaz AF; Gallardo N; Leánez S; Balboni G; Pol O
    Front Pharmacol; 2019; 10():283. PubMed ID: 30971925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further studies on lead compounds containing the opioid pharmacophore Dmt-Tic.
    Balboni G; Fiorini S; Baldisserotto A; Trapella C; Sasaki Y; Ambo A; Marczak ED; Lazarus LH; Salvadori S
    J Med Chem; 2008 Aug; 51(16):5109-17. PubMed ID: 18680274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative evaluation of human delta opioid receptor desensitization using the operational model of drug action.
    Navratilova E; Waite S; Stropova D; Eaton MC; Alves ID; Hruby VJ; Roeske WR; Yamamura HI; Varga EV
    Mol Pharmacol; 2007 May; 71(5):1416-26. PubMed ID: 17322005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. δ-Opioid receptors up-regulate excitatory amino acid transporters in mouse astrocytes.
    Liang J; Chao D; Sandhu HK; Yu Y; Zhang L; Balboni G; Kim DH; Xia Y
    Br J Pharmacol; 2014 Dec; 171(23):5417-30. PubMed ID: 25052197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of benzimidazole (Bid) in the delta-opioid agonist pseudopeptide H-Dmt-Tic-NH-CH(2)-Bid (UFP-502).
    Salvadori S; Fiorini S; Trapella C; Porreca F; Davis P; Sasaki Y; Ambo A; Marczak ED; Lazarus LH; Balboni G
    Bioorg Med Chem; 2008 Mar; 16(6):3032-8. PubMed ID: 18178091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deltorphin II-induced rapid desensitization of delta-opioid receptor requires both phosphorylation and internalization of the receptor.
    Law PY; Kouhen OM; Solberg J; Wang W; Erickson LJ; Loh HH
    J Biol Chem; 2000 Oct; 275(41):32057-65. PubMed ID: 10893226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The novel δ opioid receptor agonist KNT-127 produces antidepressant-like and antinociceptive effects in mice without producing convulsions.
    Saitoh A; Sugiyama A; Nemoto T; Fujii H; Wada K; Oka J; Nagase H; Yamada M
    Behav Brain Res; 2011 Oct; 223(2):271-9. PubMed ID: 21565223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the Dmt-Tic pharmacophore: conversion of a potent delta-opioid receptor antagonist into a potent delta agonist and ligands with mixed properties.
    Balboni G; Guerrini R; Salvadori S; Bianchi C; Rizzi D; Bryant SD; Lazarus LH
    J Med Chem; 2002 Jan; 45(3):713-20. PubMed ID: 11806723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.